Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02202421 · ClinicalTrials.gov registry record · NA
T-ABA Group Based Early Intervention For Parents of Children With ASD
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02202421 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 21 participants.
The verdict
NCT02202421, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study is a 10-week, randomized, parallel groups design which will evaluate the efficacy of T-ABA with combined parent training and individual child sessions versus T-ABA with individual sessions alone. T-ABA refers to Targeted Applied Behavior Analysis treatment, a form of behavior therapy used to promote skill development and reduce disruptive behavior in individuals with autism. Four key outcome assessment points will be used: baseline (week 0), midpoint (week 5), end-of-study (week 10), and follow-up (week 20). Participants receiving T-ABA parent training only will be offered eight individual therapy sessions at the end of the study. Total study participation is estimated to be \~ 10 weeks with a single follow-up assessment.
Interventions
- BEHAVIORAL Targeted Applied Behavior Analysis (T-ABA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02202421
The ClinicalTrials.gov registry entry for NCT02202421 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Targeted Applied Behavior Analysis (T-ABA) is the first listed.
NCT02202421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02202421 about?
NCT02202421 is a clinical study titled "T-ABA Group Based Early Intervention For Parents of Children With ASD". This study is a 10-week, randomized, parallel groups design which will evaluate the efficacy of T-ABA with combined parent training and individual child sessions versus T-ABA with individual sessions alone. T-ABA refers to Targeted Applied Behavior Analysis treatment, a form of behavior therapy used...
What is the current status of trial NCT02202421?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2015-01. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02202421?
The interventions under investigation include: Targeted Applied Behavior Analysis (T-ABA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02202421?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.